{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:27:32Z","timestamp":1791206852981,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,8,12]],"date-time":"2007-08-12T00:00:00Z","timestamp":1186876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1038\/ng2096","type":"journal-article","created":{"date-parts":[[2007,8,12]],"date-time":"2007-08-12T17:37:29Z","timestamp":1186940249000},"page":"1145-1150","source":"Crossref","is-referenced-by-count":171,"title":["RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis"],"prefix":"10.1038","volume":"39","author":[{"given":"Vivek","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Coumoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-Xia","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,12]]},"reference":[{"key":"BFng2096_CR1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S0030-6665(05)70280-2","volume":"33","author":"JT Katzen","year":"2000","unstructured":"Katzen, J.T. & McCarthy, J.G. Syndromes involving craniosynostosis and midface hypoplasia. Otolaryngol Clin. North Am. 33, 1257\u20131284 (2000).","journal-title":"Otolaryngol Clin. North Am."},{"key":"BFng2096_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0168-9525(00)89088-5","volume":"11","author":"M Muenke","year":"1995","unstructured":"Muenke, M. & Schell, U. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet. 11, 308\u2013313 (1995).","journal-title":"Trends Genet."},{"key":"BFng2096_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s003810000320","volume":"16","author":"D Renier","year":"2000","unstructured":"Renier, D., Lajeunie, E., Arnaud, E. & Marchac, D. Management of craniosynostoses. Childs Nerv. Syst. 16, 645\u2013658 (2000).","journal-title":"Childs Nerv. Syst."},{"key":"BFng2096_CR4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.PRS.0000146703.08958.95","volume":"115","author":"OA Ibrahimi","year":"2005","unstructured":"Ibrahimi, O.A., Chiu, E.S., McCarthy, J.G. & Mohammadi, M. Understanding the molecular basis of Apert syndrome. Plast. Reconstr. Surg. 115, 264\u2013270 (2005).","journal-title":"Plast. Reconstr. Surg."},{"key":"BFng2096_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ng0596-48","volume":"13","author":"DM Moloney","year":"1996","unstructured":"Moloney, D.M. et al. Exclusive paternal origin of new mutations in Apert syndrome. Nat. Genet. 13, 48\u201353 (1996).","journal-title":"Nat. Genet."},{"key":"BFng2096_CR6","first-page":"321","volume":"57","author":"WJ Park","year":"1995","unstructured":"Park, W.J. et al. Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am. J. Hum. Genet. 57, 321\u2013328 (1995).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng2096_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/bdrc.10025","volume":"69","author":"X Coumoul","year":"2003","unstructured":"Coumoul, X. & Deng, C.X. Roles of FGF receptors in mammalian development and congenital diseases. Birth Defects Res. C Embryo Today 69, 286\u2013304 (2003).","journal-title":"Birth Defects Res. C Embryo Today"},{"key":"BFng2096_CR8","volume-title":"Genome Biol","author":"DM Ornitz","year":"2001","unstructured":"Ornitz, D.M. & Itoh, N. Fibroblast growth factors. Genome Biol. 2 REVIEWS3005 (2001) (doi:10.1186\/gb-2001-2-3-reviews3005)."},{"key":"BFng2096_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1677\/erc.0.0070165","volume":"7","author":"CJ Powers","year":"2000","unstructured":"Powers, C.J., McLeskey, S.W. & Wellstein, A. Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer 7, 165\u2013197 (2000).","journal-title":"Endocr. Relat. Cancer"},{"key":"BFng2096_CR10","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.2741\/1671","volume":"10","author":"L Chen","year":"2005","unstructured":"Chen, L. & Deng, C.X. Roles of FGF signaling in skeletal development and human genetic diseases. Front. Biosci. 10, 1961\u20131976 (2005).","journal-title":"Front. Biosci."},{"key":"BFng2096_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1247\/csf.25.85","volume":"25","author":"I McIntosh","year":"2000","unstructured":"McIntosh, I., Bellus, G.A. & Jab, E.W. The pleiotropic effects of fibroblast growth factor receptors in mammalian development. Cell Struct. Funct. 25, 85\u201396 (2000).","journal-title":"Cell Struct. Funct."},{"key":"BFng2096_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S8756-3282(03)00222-9","volume":"33","author":"L Chen","year":"2003","unstructured":"Chen, L., Li, D., Li, C., Engel, A. & Deng, C.X.A. Ser252Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 33, 169\u2013178 (2003).","journal-title":"Bone"},{"key":"BFng2096_CR13","doi-asserted-by":"publisher","first-page":"5860","DOI":"10.1073\/pnas.93.12.5860","volume":"93","author":"M Lakso","year":"1996","unstructured":"Lakso, M. et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA 93, 5860\u20135865 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng2096_CR14","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1093\/nar\/gni100","volume":"33","author":"X Coumoul","year":"2005","unstructured":"Coumoul, X., Shukla, V., Li, C., Wang, R.H. & Deng, C.X. Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference. Nucleic Acids Res. 33, e102 (2005) (doi:10.1093\/nar\/gni100).","journal-title":"Nucleic Acids Res."},{"key":"BFng2096_CR15","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1093\/nar\/gnh083","volume":"32","author":"X Coumoul","year":"2004","unstructured":"Coumoul, X., Li, W., Wang, R.H. & Deng, C. Inducible suppression of Fgfr2 and Survivin in ES cells using a combination of the RNA interference (RNAi) and the Cre-LoxP system. Nucleic Acids Res. 32, e85 (2004).","journal-title":"Nucleic Acids Res."},{"key":"BFng2096_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm1205","volume":"11","author":"GS Ralph","year":"2005","unstructured":"Ralph, G.S. et al. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat. Med. 11, 429\u2013433 (2005).","journal-title":"Nat. Med."},{"key":"BFng2096_CR17","doi-asserted-by":"publisher","first-page":"31444","DOI":"10.1074\/jbc.M910132199","volume":"275","author":"D Chikazu","year":"2000","unstructured":"Chikazu, D. et al. Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42\/p44 MAP kinase. J. Biol. Chem. 275, 31444\u201331450 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFng2096_CR18","doi-asserted-by":"publisher","first-page":"36181","DOI":"10.1074\/jbc.M206057200","volume":"277","author":"G Xiao","year":"2002","unstructured":"Xiao, G., Jiang, D., Gopalakrishnan, R. & Franceschi, R.T. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1\/Runx2. J. Biol. Chem. 277, 36181\u201336187 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFng2096_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1006\/bbrc.1997.7256","volume":"238","author":"LR Chaudhary","year":"1997","unstructured":"Chaudhary, L.R. & Avioli, L.V. Activation of extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2) by FGF-2 and PDGF-BB in normal human osteoblastic and bone marrow stromal cells: differences in mobility and in-gel renaturation of ERK1 in human, rat, and mouse osteoblastic cells. Biochem. Biophys. Res. Commun. 238, 134\u2013139 (1997).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFng2096_CR20","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/01.PRS.0000153035.73507.7B","volume":"115","author":"JA Spector","year":"2005","unstructured":"Spector, J.A. et al. FGF-2 acts through an ERK1\/2 intracellular pathway to affect osteoblast differentiation. Plast. Reconstr. Surg. 115, 838\u2013852 (2005).","journal-title":"Plast. Reconstr. Surg."},{"key":"BFng2096_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/dvdy.10319","volume":"227","author":"HJ Kim","year":"2003","unstructured":"Kim, H.J. et al. Erk pathway and activator protein 1 play crucial roles in FGF2-stimulated premature cranial suture closure. Dev. Dyn. 227, 335\u2013346 (2003).","journal-title":"Dev. Dyn."},{"key":"BFng2096_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1385\/MB:31:2:151","volume":"31","author":"H Rubinfeld","year":"2005","unstructured":"Rubinfeld, H. & Seger, R. The ERK cascade: a prototype of MAPK signaling. Mol. Biotechnol. 31, 151\u2013174 (2005).","journal-title":"Mol. Biotechnol."},{"key":"BFng2096_CR23","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1160\/TH03-04-0217","volume":"90","author":"MA Cabrita","year":"2003","unstructured":"Cabrita, M.A. & Christofori, G. Sprouty proteins: antagonists of endothelial cell signaling and more. Thromb. Haemost. 90, 586\u2013590 (2003).","journal-title":"Thromb. Haemost."},{"key":"BFng2096_CR24","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1242\/dev.01699","volume":"132","author":"TG Smith","year":"2005","unstructured":"Smith, T.G., Sweetman, D., Patterson, M., Keyse, S.M. & Munsterberg, A. Feedback interactions between MKP3 and ERK MAP kinase control scleraxis expression and the specification of rib progenitors in the developing chick somite. Development 132, 1305\u20131314 (2005).","journal-title":"Development"},{"key":"BFng2096_CR25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ncb750","volume":"4","author":"M Furthauer","year":"2002","unstructured":"Furthauer, M., Lin, W., Ang, S.L., Thisse, B. & Thisse, C. Sef is a feedback-induced antagonist of Ras\/MAPK-mediated FGF signalling. Nat. Cell Biol. 4, 170\u2013174 (2002).","journal-title":"Nat. Cell Biol."},{"key":"BFng2096_CR26","doi-asserted-by":"publisher","first-page":"18623","DOI":"10.1074\/jbc.273.29.18623","volume":"273","author":"MF Favata","year":"1998","unstructured":"Favata, M.F. et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623\u201318632 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFng2096_CR27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1227\/01.NEU.0000224323.53866.1E","volume":"59","author":"CA Perlyn","year":"2006","unstructured":"Perlyn, C.A., Morriss-Kay, G., Darvann, T., Tenenbaum, M. & Ornitz, D.M. A model for the pharmacological treatment of Crouzon syndrome. Neurosurgery 59, 210\u2013215 (2006).","journal-title":"Neurosurgery"},{"key":"BFng2096_CR28","doi-asserted-by":"publisher","first-page":"18603","DOI":"10.1073\/pnas.0609157103","volume":"103","author":"VP Eswarakumar","year":"2006","unstructured":"Eswarakumar, V.P. et al. Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis. Proc. Natl. Acad. Sci. USA 103, 18603\u201318608 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng2096_CR29","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.1073\/pnas.082117599","volume":"99","author":"G Sui","year":"2002","unstructured":"Sui, G. et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 99, 5515\u20135520 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng2096_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1083\/jcb.153.1.35","volume":"153","author":"X Yang","year":"2001","unstructured":"Yang, X. et al. TGF-beta\/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J. Cell Biol. 153, 35\u201346 (2001).","journal-title":"J. Cell Biol."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng2096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng2096","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng2096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:14:46Z","timestamp":1684448086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng2096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,12]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["BFng2096"],"URL":"https:\/\/doi.org\/10.1038\/ng2096","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,12]]}}}